Functional characterization of human xanthine oxidase allelic variants

Pharmacogenetics and Genomics

Volumn 18, Issue 3, 2008, Pages 243-251

  Kudo, Mutsumi ^a   Moteki, Toshiko ^a   Sasaki, Takamitsu ^a   Konno, Yumiko ^a   Ujiie, Shuta ^a   Onose, Akemi ^a   Mizugaki, Michinao ^a   Ishikawa, Masaaki ^a   Hiratsuka, Masahiro ^a  

^a TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Function; Genetic polymorphism; Nonsynonymous single nucleotide polymorphism; Xanthine oxidase

Indexed keywords

XANTHINE OXIDASE;

ALLELE; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DATA BASE; ENZYME ACTIVITY; GENE; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; JAPANESE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE; XANTHINURIA; XO GENE;

ALLELES; ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLONING, MOLECULAR; COS CELLS; DNA PRIMERS; HUMANS; JAPAN; KINETICS; MUTAGENESIS, SITE-DIRECTED; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOMBINANT PROTEINS; VARIATION (GENETICS); XANTHINE; XANTHINE OXIDASE;

EID: 40049090510     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e3282f55e2e     Document Type: Article

References (40)

1. Pritsos CA. Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem Biol Interact 2000; 129:195-208.
2. Kitamura S, Sugihara K, Ohta S. Drug-metabolizing ability of molybdenum hydroxylases. Drug Metab Pharmacokinet 2006; 21:83-98.
3. 2- dependent type. Amino acid sequence of rat liver xanthine dehydrogenase and identification of the cleavage sites of the enzyme protein during irreversible conversion by trypsin. J Biol Chem 1990; 265:14170-14175.
4. Nishino T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem (Tokyo) 1994; 116:1-6.
5. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312:159-163.
6. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004; 555:589-606.
7. Xu P, Huecksteadt TP, Harrison R, Hoidal JR. Molecular cloning, tissue expression of human xanthine dehydrogenase. Biochem Biophys Res Commun 1994; 199:998-1004.
8. Saksela M, Lapatto R, Raivio KO. Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues. Biol Neonate 1998; 74:274-280.
9. Guerciolini R, Szumlanski C, Weinshilboum RM. Human liver xanthine oxidase: nature and extent of individual variation. Clin Pharmacol Ther 1991; 50:663-672.
10. Saruwatari J, Nakagawa K, Shindo J, Tajiri T, Fujieda M, Yamazaki H, et al. A population phenotyping study of three drug-metabolizing enzymes in Kyushu, Japan, with use of the caffeine test. Clin Pharmacol Ther 2002; 72:200-208.
11. Simmonds HA, Reiter S, Nishino T. Hereditary xanthinuria. In: Scriver CR, Beaudet AL, Sly SW, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-NeHill Inc; 1995. pp. 1781-1797.
12. Ichida K, Yoshida M, Sakuma R, Hosoya T. Two siblings with classical xanthinuria type 1: significance of allopurinol loading test. Intern Med 1998; 37:77-82.
13. Harkness RA, McCreanor GM, Simpson D, MacFadyen IR. Pregnancy in and incidence of xanthine oxidase deficiency. J Inherit Metab Dis 1986; 9:407-408.
14. Ichida K, Amaya Y, Noda K, Minoshima S, Hosoya T, Sakai O, et al. Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase): structural analysis of the protein and chromosomal location of the gene. Gene 1993; 133:279-284.
15. Xu P, Zhu XL, Huecksteadt TP, Brothman AR, Hoidal JR. Assignment of human xanthine dehydrogenase gene to chromosome 2p22. Genomics 1994; 23:289-291.
16. Minoshima S,Wang Y, Ichida K, Nishino T, Shimizu N. Mapping of the gene for human xanthine dehydrogenase (oxidase) (XDH) to band p23 of chromosome 2. Cytogenet Cell Genet 1995; 68:52-53.
17. Ichida K, Amaya Y, Kamatani N, Nishino T, Hosoya T, Sakai O. Identification of two mutations in human xanthine dehydrogenase gene responsible for classical type I xanthinuria. J Clin Invest 1997; 99:2391-2397.
18. Levartovsky D, Lagziel A, Sperling O, Liberman U, Yaron M, Hosoya T, et al. XDH gene mutation is the underlying cause of classical xanthinuria: a second report. Kidney Int 2000; 57:2215-2220.
19. Sakamoto N, Yamamoto T, Moriwaki Y, Teranishi T, Toyoda M, Onishi Y, et al. Identification of a new point mutation in the human xanthine dehydrogenase gene responsible for a case of classical type I xanthinuria. Hum Genet 2001; 108:279-283.
20. Gok F, Ichida K, Topaloglu R. Mutational analysis of the xanthine dehydrogenase gene in a Turkish family with autosomal recessive classical xanthinuria. Nephrol Dial Transplant 2003; 18:2278-2283.
21. Kalow W, Tang BK. The use of caffeine for enzyme assays: a critical appraisal. Clin Pharmacol Ther 1993; 53:503-514.
22. Aklillu E, Carrillo JA, Makonnen E, Bertilsson L, Ingelman-Sundberg M. Xanthine oxidase activity is influenced by environmental factors in Ethiopians. Eur J Clin Pharmacol 2003; 59:533-536.
23. Pfeffer KD, Huecksteadt TP, Hoidal JR. Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation. J Immunol 1994; 153:1789-1797.
24. Hille R, Nishino T. Xanthine oxidase and xanthine dehydrogenase. FASEB J 1995; 9:995-1003.
25. Okamoto K, Kuwabara Y, Nishino T. Molecular switching mechanism of xanthine oxidoreductase. Tanpakushitsu Kakusan Koso 2004; 49:625-633.
26. Enroth C, Eger BT, Okamoto K, Nishino T, Pai EF. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proc Natl Acad Sci U S A 2000; 97:10723-10728.
27. Nishino T, Okamoto K. The role of the [2Fe-2s] cluster centers in xanthine oxidoreductase. J Inorg Biochem 2000; 82:43-49.
28. Nishino T. The conversion from the dehydrogenase type to the oxidase type of rat liver xanthine dehydrogenase by modification of cysteine residues with fluorodinitrobenzene. J Biol Chem 1997; 272:29859-29864.
29. Arikyants N, Sarkissian A, Hesse A, Eggermann T, Leumann E, Steinmann B. Xanthinuria type I: a rare cause of urolithiasis. Pediatr Nephrol 2007; 22:310-314.
30. Nishino T, Okamoto K, Kawaguchi Y, Hori H, Matsumura T, Eger BT, et al. Mechanism of the conversion of xanthine dehydrogenase to xanthine oxidase: identification of the two cysteine disulfide bonds and crystal structure of a non-convertible rat liver xanthine dehydrogenase mutant. J Biol Chem 2005; 280:24888-24894.
31. Glatigny A, Hof P, Romao MJ, Huber R, Scazzocchio C. Altered specificity mutations define residues essential for substrate positioning in xanthine dehydrogenase. J Mol Biol 1998; 278:431-438.
32. Schwab M, Schaffeler E, Marx C, Fischer C, Lang T, Behrens C, et al. Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism. Pharmacogenetics 2002; 12:429-436.
33. Marinaki AM, Ansari A, Duley JA, Arenas M, Sumi S, Lewis CM, et al. Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase). Pharmacogenetics 2004; 14:181-187.
34. Ishioka S, Hiyama K, Sato H, Yamanishi Y, McLeod HL, Kumagai K, et al. Thiopurine methyltransferase genotype and the toxicity of azathioprine in Japanese. Intern Med 1999; 38:944-947.
35. Relling MV, Hancock ML, Rivera GK, Sandlund JT, Ribeiro RC, Krynetski EY, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst 1999; 91:2001-2008.
36. Sumi S, Marinaki AM, Arenas M, Fairbanks L, Shobowale-Bakre M, Rees DC, et al. Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency. Hum Genet 2002; 111:360-367.
37. Giverhaug T, Loennechen T, Aarbakke J. The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX). Gen Pharmacol 1999; 33:341-346.
38. Tamta H, Kalra S, Mukhopadhyay AK. Differential nature of substrate affinity, kinetics and electron transfer reaction displayed by xanthine and 6-thioxanthine as substrates of milk xanthine oxidase. J Biol Phys Chem 2005; 5:89-99.
39. Xu P, Huecksteadt TP, Hoidal JR. Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH). Genomics 1996; 34:173-180.
40. Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Matsui K, et al. Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type II. Metabolism 2003; 52:1501-1504.